Pfizer Retained Earnings (Accumulated Deficit) 2010-2024 | PFE
Pfizer retained earnings (accumulated deficit) for the quarter ending June 30, 2024 were $116.596B, a 9.47% decline year-over-year.
- Pfizer retained earnings (accumulated deficit) for 2023 were $118.353B, a 5.81% decline from 2022.
- Pfizer retained earnings (accumulated deficit) for 2022 were $125.656B, a 21.53% increase from 2021.
- Pfizer retained earnings (accumulated deficit) for 2021 were $103.394B, a 14.38% increase from 2020.